InsidersTradesSigma
광동제약 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 광동제약 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Food & Beverage sector, 광동제약 has recorded 6 reports. Market capitalisation: €303.4bn. The latest transaction was filed on 30 June 2026 (Other). Among the most active insiders: 최성원. All data is free.
6
Insider Decl.
0
Thresholds
€81,964
3 ops.
Buy Volume
·
1 ops.
Sell Volume
31Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 13,427 of 26,270 companies
51.3
score / 100
Value75
Quality27
FCF yld19%
Earn yld7.0%
EV/EBITDA10.1x
ROE3.3%
Gross mgn18%
Net mgn1.3%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 June 2026
Declarations6 total
6 of 6 declarations
About 광동제약
광동제약 is a South Korean company specializing in the manufacturing of pharmaceutical and health products. It is listed on the XKRX stock exchange.